P2RY12 and Alzheimer disease: Surprisingly, in contrast to DAM in AD mouse models, DAM in ALS models significantly up-regulated inhibitory checkpoints (Cx3cr1 and P2ry12), as validated by ISH (Fig. 6C and D).